X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49657) 49657
Publication (5114) 5114
Book Review (519) 519
Book Chapter (211) 211
Newspaper Article (175) 175
Book / eBook (159) 159
Newsletter (95) 95
Conference Proceeding (83) 83
Dissertation (46) 46
Magazine Article (33) 33
Government Document (19) 19
Data Set (7) 7
Web Resource (5) 5
Paper (4) 4
Presentation (3) 3
Streaming Video (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43087) 43087
index medicus (25989) 25989
male (20407) 20407
oncology (19238) 19238
female (18283) 18283
cancer (15570) 15570
animals (15308) 15308
middle aged (14676) 14676
aged (12946) 12946
mice (10121) 10121
adult (9440) 9440
immunotherapy (9394) 9394
tumors (8201) 8201
antigens (8011) 8011
immunology (6848) 6848
prognosis (6777) 6777
expression (6672) 6672
cell line, tumor (6297) 6297
care and treatment (6261) 6261
prostate cancer (6060) 6060
research (5848) 5848
treatment outcome (5580) 5580
chemotherapy (5409) 5409
aged, 80 and over (5252) 5252
metastasis (5202) 5202
analysis (4970) 4970
antigens, neoplasm - immunology (4694) 4694
immunohistochemistry (4693) 4693
health aspects (4604) 4604
carcinoma (4470) 4470
prostate-specific antigen - blood (4389) 4389
antineoplastic agents - therapeutic use (4253) 4253
neoplasms - immunology (4188) 4188
antigen (4149) 4149
therapy (4087) 4087
apoptosis (3952) 3952
antineoplastic combined chemotherapy protocols - therapeutic use (3895) 3895
dendritic cells (3827) 3827
prostatic neoplasms - pathology (3784) 3784
survival (3764) 3764
lymphocytes (3725) 3725
neoplasms - therapy (3720) 3720
neoplasm staging (3712) 3712
proteins (3708) 3708
medicine, research & experimental (3701) 3701
antibodies, monoclonal - therapeutic use (3643) 3643
medicine (3582) 3582
t cells (3549) 3549
hematology (3547) 3547
gene expression (3541) 3541
article (3507) 3507
research article (3368) 3368
urology & nephrology (3198) 3198
breast cancer (3178) 3178
melanoma (3117) 3117
cell biology (3097) 3097
pathology (3066) 3066
cancer therapies (3047) 3047
surgery (3002) 3002
retrospective studies (2966) 2966
patients (2952) 2952
medicine & public health (2902) 2902
diagnosis (2854) 2854
prostatic neoplasms - drug therapy (2789) 2789
multidisciplinary sciences (2769) 2769
flow cytometry (2710) 2710
t-lymphocytes - immunology (2705) 2705
genetic aspects (2669) 2669
cells (2639) 2639
immunotherapy - methods (2630) 2630
development and progression (2586) 2586
cancer vaccines - therapeutic use (2511) 2511
prostatic neoplasms - blood (2511) 2511
medical prognosis (2500) 2500
cancer vaccines - immunology (2495) 2495
disease-free survival (2488) 2488
medical research (2451) 2451
follow-up studies (2428) 2428
biomarkers (2379) 2379
combined modality therapy (2378) 2378
in-vivo (2372) 2372
time factors (2347) 2347
science (2329) 2329
cell proliferation (2322) 2322
risk factors (2306) 2306
stem cells (2275) 2275
radiotherapy (2212) 2212
tumor cells, cultured (2203) 2203
mice, inbred c57bl (2189) 2189
survival analysis (2187) 2187
disease progression (2182) 2182
prostate-specific antigen (2174) 2174
biochemistry & molecular biology (2170) 2170
breast-cancer (2156) 2156
metastases (2138) 2138
biomarkers, tumor - metabolism (2116) 2116
gene expression regulation, neoplastic (2107) 2107
biomarkers, tumor - blood (2105) 2105
mice, inbred balb c (2104) 2104
dendritic cells - immunology (2084) 2084
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (115) 115
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Online Resources - Online (5) 5
Toronto East General Hospital - Stacks (3) 3
Trinity College (John W Graham) - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (48870) 48870
Japanese (495) 495
French (305) 305
German (277) 277
Chinese (239) 239
Russian (101) 101
Spanish (85) 85
Italian (53) 53
Polish (33) 33
Hungarian (24) 24
Danish (13) 13
Portuguese (11) 11
Korean (8) 8
Dutch (7) 7
Czech (6) 6
Romanian (6) 6
Finnish (5) 5
Serbian (5) 5
Norwegian (4) 4
Swedish (4) 4
Bulgarian (3) 3
Hebrew (3) 3
Ukrainian (3) 3
Bosnian (2) 2
Turkish (2) 2
Arabic (1) 1
Croatian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Immunotherapy, ISSN 1524-9557, 02/2013, Volume 36, Issue 2, pp. 133 - 151
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 35, pp. 8968 - 8977
Journal Article
Nature, ISSN 0028-0836, 2017, Volume 552, Issue 7683, pp. 1 - 5
Journal Article
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 11/2001, Volume 1, Issue 2, pp. 118 - 129
A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of... 
ENZYME PRODRUG THERAPY | B-CELL LYMPHOMA | COMPLEMENTARITY-DETERMINING REGIONS | ANTI-CD20 MONOCLONAL-ANTIBODY | ONCOLOGY | METASTATIC BREAST-CANCER | SINGLE-CHAIN FV | ACUTE MYELOID-LEUKEMIA | RESHAPING HUMAN-ANTIBODIES | ENDOTHELIAL GROWTH-FACTOR | HUMAN CARBOXYPEPTIDASE A1 | Prodrugs - administration & dosage | Recombinant Fusion Proteins - immunology | Antibodies, Neoplasm - therapeutic use | Immunotherapy - methods | Humans | Recombinant Fusion Proteins - therapeutic use | Neoplasm Proteins - immunology | Antibodies, Monoclonal - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Drug Delivery Systems | Neoplasm, Residual | Antibodies, Monoclonal, Humanized | Clinical Trials, Phase III as Topic | Neoplasms - therapy | Protein Engineering | Antibodies - immunology | Immunoconjugates - therapeutic use | Neoplasms - radiotherapy | Neovascularization, Pathologic - immunology | Antibodies, Monoclonal - immunology | Neovascularization, Pathologic - therapy | Antibodies - therapeutic use | Cytokines - therapeutic use | Antibodies, Neoplasm - immunology | Antibodies, Monoclonal, Murine-Derived | Antibody-Dependent Cell Cytotoxicity | Antigens, Neoplasm - immunology | Radioimmunotherapy | Rituximab | Treatment Outcome | Combined Modality Therapy | Cytokines - administration & dosage | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Antibodies, Bispecific - therapeutic use | Animals | Immunotoxins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Immunization, Passive | Mice | Liposomes | Neoplasms - pathology | Trastuzumab | Clinical Trials, Phase II as Topic | Viral antibodies | Usage | Care and treatment | Antibodies | Research | Health aspects | Methods | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 08/2011, Volume 71, Issue 15, pp. 5134 - 5143
Antibody-dependent cell cytotoxicity (ADCC) plays a critical role in monoclonal antibody (mAb)-mediated cancer therapy. ADCC, however, has not been directly... 
B-CELL | ONCOLOGY | CYCLOPHOSPHAMIDE | METASTATIC BREAST-CANCER | IN-VIVO | LYMPHOMA | MONOCLONAL-ANTIBODY | ANTITUMOR-ACTIVITY | C-RECEPTOR POLYMORPHISMS | T-CELLS | ANTIGEN | Mammary Neoplasms, Experimental - immunology | Antibody Specificity | Antibodies, Neoplasm - therapeutic use | Breast Neoplasms - immunology | Humans | Ovarian Neoplasms - pathology | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents, Alkylating - pharmacology | Antigens, Tumor-Associated, Carbohydrate - immunology | Cystadenocarcinoma, Serous - pathology | Cyclophosphamide - therapeutic use | Antibodies, Monoclonal, Humanized | Female | Cystadenocarcinoma, Serous - immunology | Macrophages - immunology | Mammary Neoplasms, Experimental - drug therapy | Immunological Synapses - ultrastructure | Antibody-Dependent Cell Cytotoxicity | Antibodies, Monoclonal - pharmacology | Neutrophils - immunology | Combined Modality Therapy | Receptors, IgG - immunology | Mammary Neoplasms, Experimental - therapy | Antineoplastic Agents, Alkylating - therapeutic use | Tumor Microenvironment - immunology | Animals | Breast Neoplasms - pathology | Cell Line, Tumor - immunology | Cyclophosphamide - pharmacology | Immunological Synapses - immunology | Immunization, Passive | Mice | Mice, Inbred BALB C | Trastuzumab | Ovarian Neoplasms - immunology | Index Medicus | Tumor Microenvironment | Macrophages | Breast Neoplasms | Life Sciences | Antigens, Tumor-Associated, Carbohydrate | Cystadenocarcinoma, Serous | Ovarian Neoplasms | Antibodies, Neoplasm | Antineoplastic Agents, Alkylating | Biochemistry, Molecular Biology | Neutrophils | Antibodies, Monoclonal | Immunological Synapses | Receptors, IgG | Cyclophosphamide | Mammary Neoplasms, Experimental | Cell Line, Tumor | Cancer
Journal Article
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 06/2009, Volume 32, Issue 5, pp. 498 - 507
In mice, injection of messenger RNA (mRNA) coding for tumor-associate antigens can induce antitumor immune responses and therefore offers a broadly applicable... 
Protamine-protected mRNA | Vaccination | Melanoma | mRNA vaccination | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PROTEIN | DENDRITIC CELLS | melanoma | PERIPHERAL-BLOOD | INDUCTION | IMMUNOLOGY | CYTOTOXIC T-LYMPHOCYTES | CANCER-PATIENTS | ONCOLOGY | DNA | IN-VIVO | protamine-protected mRNA | vaccination | ANTIGEN | Cell Proliferation | HLA-DR Antigens | Humans | Lung Neoplasms - metabolism | Middle Aged | Neoplasm Proteins - immunology | Bone Neoplasms - secondary | CD4 Antigens | Male | RNA, Messenger - metabolism | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Antigens, Neoplasm - therapeutic use | Myeloid Cells - immunology | Cancer Vaccines | Antigens, Neoplasm - metabolism | Neoplasm Proteins - genetics | Melanoma-Specific Antigens | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Antigens, Neoplasm - immunology | Neoplasm Proteins - therapeutic use | Bone Neoplasms - immunology | Lung Neoplasms - therapy | Melanoma - pathology | Remission Induction | Adolescent | Hemocyanins - metabolism | Myeloid Cells - pathology | Forkhead Transcription Factors | RNA, Messenger - therapeutic use | T-Lymphocytes, Regulatory - metabolism | Bone Neoplasms - therapy | Immunotherapy, Active | CD11b Antigen | Neoplasm Proteins - metabolism | Bone Neoplasms - metabolism | Feasibility Studies | Lung Neoplasms - secondary | Adult | Female | Injections, Intradermal | Melanoma - metabolism | Antigens, Neoplasm - genetics | RNA, Messenger - genetics | Protamines - metabolism | Lung Neoplasms - immunology | Melanoma - immunology | Myeloid Cells - metabolism | Aged | Melanoma - therapy | Neoplasm Staging | Index Medicus
Journal Article